PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute for Global Health Sciences, UCSF, San Francisco, California, USA.\', \'Partners In Health, Freetown, Sierra Leone.\', \'Connaught Hospital, University of Sierra Leone Teaching Hospitals Complex, Ministry of Health and Sanitation, Freetown, Sierra Leone.\', \'Sierra Leone Ministry of Health and Sanitation, Freetown, Western Area Urban, Sierra Leone.\', \'Department of Epidemiology and Biostatistics, UCSF, San Francisco, California, USA.\', \'Statistics Sierra Leone, Freetown, Sierra Leone.\', \'Njala University, Bo, Sierra Leone.\', \'HIGH, University of Heidelberg, Heidelberg, Germany.\', \'School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.\', \'Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.\', \'Temple University School of Medicine, Philadelphia, Pennsylvania, USA.\', \'Department of Humanities and Social Sciences, UCSF, San Francisco, California, USA.\', \'Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.\', \'Centers for Disease Control and Prevention, Atlanta, Georgia, USA.\', \'COMAHS, Freetown, Western Area Urban, Sierra Leone.\', \'Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA eugene_richardson@hms.harvard.edu.\', \'Division of Infectious Diseases, Brigham and Women\'s Hospital, Boston, Massachusetts, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • e00727110.1136/bmjgh-2021-007271
?:doi
?:hasPublicationType
?:journal
  • BMJ global health
is ?:pmid of
?:pmid
?:pmid
  • 34764148
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all